Literature DB >> 29198054

A case of unusually long survival after leptomeningeal carcinomatosis diagnosis.

Marianna Riolo1,2, Emilio Ciusani3, Andrea Salmaggi4.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 29198054     DOI： 10.1007/s11060-017-2705-4

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


× No keyword cloud information.
  4 in total

1.  Meningeal carcinomatosis in breast cancer: prognostic factors and outcome.

Authors:  Carla Rameri Alexandre Silva de Azevedo; Marcelo Rocha Sousa Cruz; Ludmilla Thomé Domingos Chinen; Stela Verzinhasse Peres; Marcos Aurélio Peterlevitz; Artur Eugênio de Azevedo Pereira; Marcello Ferretti Fanelli; Daniel Luiz Gimenes
Journal:  J Neurooncol       Date:  2011-01-14       Impact factor: 4.130

2.  Cerebrospinal fluid tumor marker levels in predicting response to treatment and survival of carcinomatous meningitis in patients with advanced breast cancer.

Authors:  Christos Kosmas; Nicolas B Tsavaris; George Tsakonas; Georgia Soukouli; Argyris Gassiamis; Nicolas Mylonakis; Athanasios Karabelis
Journal:  Med Sci Monit       Date:  2005-07-25

3.  EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours.

Authors:  E Le Rhun; M Weller; D Brandsma; M Van den Bent; E de Azambuja; R Henriksson; T Boulanger; S Peters; C Watts; W Wick; P Wesseling; R Rudà; M Preusser
Journal:  Ann Oncol       Date:  2017-07-01       Impact factor: 32.976

4.  Breast cancer and leptomeningeal disease (LMD): hormone receptor status influences time to development of LMD and survival from LMD diagnosis.

Authors:  S Yust-Katz; P Garciarena; D Liu; Y Yuan; N Ibrahim; R Yerushalmi; M Penas-Prado; M D Groves
Journal:  J Neurooncol       Date:  2013-06-12       Impact factor: 4.130
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.